US patent granted for movement recording
GKC has received notification of issuance by the US patent office of a patent covering its key product the Personal KinetiGraph™ (PKG™).
This US patent, number 9,826,921, has now been granted to GKC, and is for the objective measurement of bradykinesia. This includes the detection of hypokinetic states in Parkinson’s diseases and underpins the PKG™ technology.
Granting of this patent further supports GKC’s success in commercializing the PKG™ System in the highly-valued US market and cements the company’s lead product as the only commercially available digital health technology providing clinically meaningful continuous measurement of the key symptoms of Parkinson’s disease.